trihexyphenidyl has been researched along with Dermatitis, Seborrheic in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Dermatitis, Seborrheic: A chronic inflammatory disease of the skin with unknown etiology. It is characterized by moderate ERYTHEMA, dry, moist, or greasy (SEBACEOUS GLAND) scaling and yellow crusted patches on various areas, especially the scalp, that exfoliate as dandruff. Seborrheic dermatitis is common in children and adolescents with HIV INFECTIONS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sandyk, R | 1 |
1 other study available for trihexyphenidyl and Dermatitis, Seborrheic
Article | Year |
---|---|
Alpha-melanocyte-stimulating hormone: possible role in the pathophysiology of acute drug-induced dystonia.
Topics: alpha-MSH; Child; Dermatitis, Seborrheic; Dyskinesia, Drug-Induced; Female; Humans; Hydroxyzine; Mov | 1990 |